Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 1/20 | 0.35 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.34 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31077729 | 0.87 | MAPK14 (0.39) | HTR1AMTNR1AMTNR1BALDH1A1LMNA | |
| SCHEMBL25747852 | 0.87 | MAPK14 (0.39) | HTR1AMTNR1AMTNR1BALDH1A1LMNA | |
| SCHEMBL25422956 | 0.87 | HTR1A (0.47) | HTR1AMTNR1AMTNR1BALDH1A1LMNA | |
| SCHEMBL25747868 | 0.85 | MEN1 (0.36) | MTNR1AMTNR1BALDH1A1 | |
| SCHEMBL25436706 | 0.83 | ALDH1A1 (0.38) | HTR1AMTNR1AMTNR1BALDH1A1LMNA | |
| SCHEMBL25423229 | 0.83 | NR4A2 (0.33) | ALDH1A1LMNAMAPTNR4A2 | |
| SCHEMBL25436610 | 0.81 | NR4A2 (0.36) | MTNR1AMTNR1BNR4A2 | |
| SCHEMBL31077662 | 0.79 | GABRP (0.41) | MTNR1AMTNR1BLMNAMAPTNR4A2 | |
| SCHEMBL25289183 | 0.79 | GABRP (0.41) | MTNR1AMTNR1BLMNAMAPTNR4A2 | |
| SCHEMBL17417724 | 0.77 | PRKAB2 (0.46) | MTNR1AMTNR1BALDH1A1MAPTNR4A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250101038-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2025-03-27 | — | — | US | disclosed |
| CN-118715204-A | Compounds of formula (I) | 普赛洛私人有限公司 | 2024-09-27 | — | — | CN | disclosed |
| WO-2023115166-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2023-06-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250101038-A1 | COMPOUNDS | NLN, SLC18A2, PYGB | HTR1A 185/4885MTNR1A 888/4885MTNR1B 461/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.